跳至主要内容
临床试验/NCT07418619
NCT07418619招募中不适用

Minimum Effective Exercise Intensity for Improving Cardiorespiratory Fitness and Cardiometabolic Health in Sedentary Individuals

UKK Institute2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2026年2月23日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
2
主要终点
Maximal oxygen consumption

研究概览

简要总结

The aim of this randomized controlled intervention study is to examine the minimum exercise intensity that has an effect on cardiorespiratory fitness and/or cardiometabolic risk factors in sedentary adults. In addition, the study seeks to examine which background factors explain individual differences in exercise responses.

详细描述

The study consists of a 2-week baseline period followed by two 6-week intervention periods. The study will compare changes in the predefined outcome variables between the exercise intervention groups and the control group that does not perform any exercise training. In addition to intensity prescribed relative to oxygen uptake reserve, exercise intensity will be retrospectively analyzed in relation to the first ventilatory threshold in order to examine the lowest effective intensity using this method as well. Among background factors, possible modifiers assumed on the basis of previous literature, will be analyzed to assess their contribution to inter-individual differences in the outcome responses. Potential main contributors are considered to be sex, the basal value of the outcome, nutritional habits, physical activity and stationary behavior outside the prescribed training, and non-invasive indicators of stress.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
30 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 30-50-year old males and females
  • Sedentary, not participating in regular exercise training/physical activity

排除标准

  • Cardiovascular symptoms/diseases
  • Musculoskeletal symptoms/diseases
  • Metabolic diseases
  • Resting blood pressure > 160/100 mmHg
  • Body mass index ≥ 35

研究组 & 干预措施

30 %/VO2reserve intervention group

Experimental

干预措施: Exercise (Other)

40 %/VO2reserve intervention group

Experimental

干预措施: Exercise (Other)

50 %/VO2reserve intervention group

Experimental

干预措施: Exercise (Other)

60 %/VO2reserve intervention group

Experimental

干预措施: Exercise (Other)

Control group

No Intervention

结局指标

主要结局

Maximal oxygen consumption

时间窗: Pre (week 0), mid (after 6 weeks), post (after 12 weeks)

Assessed with step-ramp-step protocol

Ventilatory thresholds

时间窗: Pre (week 0), mid (after 6 weeks), post (after 12 weeks)

Assessed with step-ramp-step protocol

次要结局

  • Pmax(Pre (week 0), mid (after 6 weeks), post (after 12 weeks))
  • Concentration of LDL cholesterol(Pre (week 0), mid (after 6 weeks), post (after 12 weeks))
  • Concentration of HDL cholesterol(Pre (week 0), mid (after 6 weeks), post (after 12 weeks))
  • Concentration of total cholesterol(Pre (week 0), mid (after 6 weeks), post (after 12 weeks))
  • Concentration of triglycerides(Pre (week 0), mid (after 6 weeks), post (after 12 weeks))
  • Concentration of blood glucose(Pre (week 0), mid (after 6 weeks), post (after 12 weeks))
  • Concentration of insulin(Pre (week 0), mid (after 6 weeks), post (after 12 weeks))
  • HOMA-IR(Pre (week 0), mid (after 6 weeks), post (after 12 weeks))
  • HbA1c(Pre (week 0), mid (after 6 weeks), post (after 12 weeks))
  • Blood pressure(Pre (week 0), mid (after 6 weeks), post (after 12 weeks))
  • Resting heart rate(Pre (week 0), mid (after 6 weeks), post (after 12 weeks))
  • Resting heart rate variability(Pre (week 0), mid (after 6 weeks), post (after 12 weeks))
  • Gross efficiency(Pre (week 0), mid (after 6 weeks), post (after 12 weeks))
  • Body weight(Pre (week 0), mid (after 6 weeks), post (after 12 weeks))
  • Waist circumference(Pre (week 0), mid (after 6 weeks), post (after 12 weeks))

研究者

发起方
UKK Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Olli-Pekka Nuuttila

Exercise physiologist

UKK Institute

研究点 (2)

Loading locations...

相似试验